Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Sphere Fluidics
Sphere Fluidics
Activities:
Manufacturing
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Analysis
Sphere Fluidics appoints Dale Levitzke as CEO
Dale Levitzke joins as Dr Frank F. Craig, current CEO and co-founder, announces his retirement
Analysis
Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics
Ed’s appointment will strengthen the company’s strategic vision as it progresses ambitious plans for future growth and commercial success
Manufacturing
Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing
Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions
Manufacturing
Sphere Fluidics' platform chosen by Biosyntia for screening capabilities
Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactives
Manufacturing
Sphere Fluidics aligns with global commercial growth strategy
The company has seen a period of significant expansion over the last twelve months, including a series of new appointments within the senior leadership team
Manufacturing
Sphere Fluidics opens UK laboratory facilities
Investment in purpose-built facilities supports ongoing recruitment and growth in new product development activities
Manufacturing
Sphere Fluidics and ClexBio launch cell analysis kit
The kit is designed to allow researchers to study valuable cells over many weeks rather than days
Subscribe now